Werewolf Therapeutics (HOWL) Preferred Dividend Payments (2020 - 2021)
Werewolf Therapeutics (HOWL) posted quarterly Preferred Dividend Payments of $29.6 million for Q2 2021, up 95445.16% year-over-year from N/an in Q2 2020, and down 40.47% on a QoQ basis from $49.8 million in Q1 2021.
Werewolf Therapeutics (HOWL) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Werewolf Therapeutics has reported Preferred Dividend Payments for 2 years, with the latest figure at $29.6 million in Q2 2021.
- Preferred Dividend Payments for Q2 2021 came in at $29.6 million, up 95445.16% year-over-year; the trailing twelve-month figure through Mar 2022 was $29.6 million (down 52.93% YoY), and the FY2021 annual result was $151.9 million, up 1053.08% from the prior year.
- Preferred Dividend Payments fell to $29.6 million in Q2 2021, from $49.8 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $49.8 million in Q1 2021 and troughed at $31000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 29.62 Mn |
| Mar 31, 2021 | 49.75 Mn |
| Dec 31, 2020 | 13.15 Mn |
| Jun 30, 2020 | 31,000.00 |